Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.250
+0.470 (60.26%)
Aug 19, 2026, 3:08 PM EST
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $2.68 million as of August 19, 2026. Its market cap has increased by 27.70% in one year.
Market Cap
2.68M
Enterprise Value
3.26M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.25
ChartMarket Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 2.68M, a decrease of -97.95%. That is a compound annual growth rate of -38.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 3.35M | 16.23% |
| Dec 31, 2025 | 2.88M | 9.74% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxxinity | 3.23M |
| Zenith Capital | 3.19M |
| Eastgate Biotech | 3.17M |
| CASI Pharmaceuticals | 3.04M |
| Enzolytics | 2.90M |
| International Stem Cell | 2.80M |
| AccuStem Sciences | 2.51M |
| Bioxytran | 2.41M |